Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Conference News NY Valves 2025

Changes in Quality of Life Mirror TR Reductions After Tricuspid Procedures: Tri-QOL

Yael L. Maxwell

July 01, 2025

News Conference News NY Valves 2025

Failure of ‘Jailed’ CIED Leads Not Uncommon After TTVR: TRIPLACE

Todd Neale

June 27, 2025

News Conference News NY Valves 2024

AV Block Common After Transcatheter Tricuspid Valve Replacement for TR

Michael O'Riordan

June 07, 2024

Presentation NY Valves 2024

RV Failure After TTVR: Frequency, Diagnosis, and Therapeutic Options

Presenter: Michael I. Brener

June 07, 2024

Presentation NY Valves 2024

Con: Heterotopic TTVR Indications Are Limited and Should Be Considered as a Last Resort!

Presenter: Azeem Latib

June 07, 2024

Presentation NY Valves 2024

Pro: Heterotopic TTVR Technologies Are Evolving, thus Their Indications Will Expand!

Presenter: Rishi Puri

June 07, 2024

Presentation NY Valves 2024

Conduction Abnormalities and Heart Block Post-TTVR: Prognostic Assessment and Therapeutic Options

Presenter: Elaine Wan

June 07, 2024

Presentation NY Valves 2024

Percutaneous Treatment of Tricuspid Regurgitation With the Novel TriFlO® Device: First in Human Italian Experience

Presenter: Gian Paolo Ussia

June 06, 2024

Presentation NY Valves 2024

Long-Term Follow Up With the DUO Coaptation Valve System for the Percutaneous Treatment of Tricuspid Regurgitation: The TANDEM I Trial

Presenter: Wojtek Wojakowski

June 06, 2024

Presentation NY Valves 2024

EFS of the Edwards SAPIEN 3 THV System With the Edwards Caval Pre-Stent for the Treatment of Reverse Caval Flow in Patients With Severe TR

Presenter: Brian P. O'Neill

June 06, 2024

Presentation NY Valves 2024

Heterotopic TTVR in Patients With Severe TR: First-in-Human Experience With the Trillium Device

Presenter: Philipp Lurz

June 06, 2024

Presentation NY Valves 2024

TricValve: Technology and Clinical Update

Presenter: Rishi Puri

June 06, 2024

Presentation NY Valves 2024

Keynote Lecture: Heterotopic TTVR: Where Do We Draw the Line in Patient Indication?

Presenter: Rodrigo D. Estevez-Loureiro

June 06, 2024

Presentation NY Valves 2024

Early Feasibility Study of the Laplace TTVR System in Patients With Severe, Symptomatic Tricuspid Regurgitation

Presenter: Thomas E. Waggoner

June 06, 2024

Presentation NY Valves 2024

The Trisol Medical TTVR System: US Experience

Presenter: Vinod H. Thourani

June 06, 2024

Presentation NY Valves 2024

The Topaz TTVR System: Technology for Expanded Patient Access and EFS Update

Presenter: Hendrik Treede

June 06, 2024

Presentation NY Valves 2024

Keynote Lecture: Impact of TTVR on Hemodynamics and Ventricular Performance: Are New Generation Technologies Addressing the Physiologic Needs?

Presenter: Philipp Lurz

June 06, 2024

Presentation NY Valves 2024

Live-in-a-Box TTVR Case with Emphasis on Intraprocedural Imaging

Presenter: Raj Makkar, Moody M. Makar

June 06, 2024

Presentation NY Valves 2024

Pro-TTVR: Total TR Resolution Must be a Goal and is a Key Factor Impacting Long-Term Outcomes

Presenter: Stephan Windecker

June 05, 2024

Advertisement

Changes in Quality of Life Mirror TR Reductions After Tricuspid Procedures: Tri-QOL

Failure of ‘Jailed’ CIED Leads Not Uncommon After TTVR: TRIPLACE

AV Block Common After Transcatheter Tricuspid Valve Replacement for TR

RV Failure After TTVR: Frequency, Diagnosis, and Therapeutic Options

Con: Heterotopic TTVR Indications Are Limited and Should Be Considered as a Last Resort!

Pro: Heterotopic TTVR Technologies Are Evolving, thus Their Indications Will Expand!

Conduction Abnormalities and Heart Block Post-TTVR: Prognostic Assessment and Therapeutic Options

Percutaneous Treatment of Tricuspid Regurgitation With the Novel TriFlO® Device: First in Human Italian Experience

Long-Term Follow Up With the DUO Coaptation Valve System for the Percutaneous Treatment of Tricuspid Regurgitation: The TANDEM I Trial

EFS of the Edwards SAPIEN 3 THV System With the Edwards Caval Pre-Stent for the Treatment of Reverse Caval Flow in Patients With Severe TR

Heterotopic TTVR in Patients With Severe TR: First-in-Human Experience With the Trillium Device

TricValve: Technology and Clinical Update

Keynote Lecture: Heterotopic TTVR: Where Do We Draw the Line in Patient Indication?

Early Feasibility Study of the Laplace TTVR System in Patients With Severe, Symptomatic Tricuspid Regurgitation

The Trisol Medical TTVR System: US Experience

The Topaz TTVR System: Technology for Expanded Patient Access and EFS Update

Keynote Lecture: Impact of TTVR on Hemodynamics and Ventricular Performance: Are New Generation Technologies Addressing the Physiologic Needs?

Live-in-a-Box TTVR Case with Emphasis on Intraprocedural Imaging

Pro-TTVR: Total TR Resolution Must be a Goal and is a Key Factor Impacting Long-Term Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content